Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer
NCT01078883 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2011-01-10
Summary
The purpose of our study is to investigate the association between respiratory muscle performance, functional capacity, dyspnea, anxiety/depression symptom, 1-year respiratory morbidity rate, and 1-year mortality in patients with primary stage IIIb and IV lung cancer.
Conditions
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chung-Chun Lai, MS. · Physical Thaerapy Center, National Taiwan University Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-03-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NCT05701787 ·Status: RECRUITING
-
Develop and Test the Effects of the 'Computer-Assisted OPD COPSCCP on Early Stage Lung Cancer Patients
NCT04506359 ·Status: RECRUITING ·Phase: NA
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
NCT00752076 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy
NCT03130192 ·Status: UNKNOWN
-
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer
NCT01885754 ·Status: UNKNOWN
-
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
NCT06326086 ·Status: RECRUITING
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China
NCT02458651 ·Status: COMPLETED
-
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
NCT04067830 ·Status: RECRUITING ·Phase: PHASE2
-
Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer
NCT03175289 ·Status: COMPLETED ·Phase: NA
-
Lung Cancer Diagnosis and Staging Using Ultrasound Guidance
NCT01623765 ·Status: COMPLETED
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
New York Better Breathing Study
NCT06869447 ·Status: RECRUITING ·Phase: NA
-
Formatting the Risk Prediction Models for Never-Smoking Lung Cancer
NCT05572944 ·Status: RECRUITING
-
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 ·Status: UNKNOWN
-
Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
NCT05778045 ·Status: NOT_YET_RECRUITING
-
The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism
NCT01280448 ·Status: UNKNOWN
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING
-
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
NCT00733252 ·Status: WITHDRAWN
-
Liquid Biopsy for Detection of Driver Mutation in NSCLC
NCT02778854 ·Status: UNKNOWN
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
NCT00897143 ·Status: WITHDRAWN